T. Sakaue

Effect of simvastatin on apoprotein B—containing lipoproteins in patients with diabetic nephropathy

M. Adachi, G. Yoshino, T. Hirano, 2002 .

An increased number of very-low-density lipoprotein particles is strongly associated with coronary heart disease in Japanese men, independently of intermediate-density lipoprotein or low-density lipoprotein

T. Katagiri, M. Adachi, S. Koba, 2002, Coronary artery disease.

[Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].

T. Katagiri, T. Kondo, S. Koba, 2000, Journal of cardiology.

Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogeneous methods.

M. Adachi, G. Yoshino, T. Hirano, 2000, Clinica chimica acta; international journal of clinical chemistry.

Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII.

M. Adachi, G. Yoshino, T. Hirano, 2003, Kidney international.

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.

G. Lewis, Shirya Rashid, Takehiko Watanabe, 2003, Clinical biochemistry.

Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men

G. Lewis, A. Carpentier, A. Giacca, 2004, Diabetologia.

Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes.

T. Katagiri, M. Adachi, S. Koba, 2002, Atherosclerosis.

Low-dose candesartan cilexetil prevents early kidney damage in type 2 diabetic patients with mildly elevated blood pressure.

M. Adachi, T. Hirano, K. Okada, 2003, Hypertension research : official journal of the Japanese Society of Hypertension.